Anavex Life Sciences Corporation’s recent filing unveils that its Director Donhauser Peter D.O. acquired Company’s shares for reported $10319.0 on Jun 14 ’24. In the deal valued at $3.64 per share,2,835 shares were bought. As a result of this transaction, Donhauser Peter D.O. now holds 5,000 shares worth roughly $67300.0.
Then, Thomas Steffen bought 5,000 shares, generating $22,600 in total proceeds. Upon buying the shares at $4.52, the Director now owns 5,000 shares.
Before that, MISSLING CHRISTOPHER U sold 73,380 shares. Anavex Life Sciences Corporation shares valued at $374,972 were divested by the President and CEO at a price of $5.11 per share. As a result of the transaction, MISSLING CHRISTOPHER U now holds 1,250,210 shares, worth roughly $16.83 million.
Cantor Fitzgerald downgraded its Anavex Life Sciences Corporation [AVXL] rating to a Neutral from a an Overweight in a research note published on December 06, 2022; the price target was decreased to $11 from $16. A number of analysts have revised their coverage, including Berenberg’s analysts, who began to cover the stock in late June with a ‘”a Buy”‘ rating. BTIG Research began covering AVXL with “Buy” recommendation on September 23, 2021. H.C. Wainwright maintained its rating on December 16, 2020. It rated AVXL as “a Buy”.
Price Performance Review of AVXL
On Tuesday, Anavex Life Sciences Corporation [NASDAQ:AVXL] saw its stock jump 2.67% to $13.46. Over the last five days, the stock has gained 21.92%. Anavex Life Sciences Corporation shares have risen nearly 25.33% since the year began. Nevertheless, the stocks have risen 123.96% over the past one year. While a 52-week high of $14.44 was reached on 01/07/25, a 52-week low of $3.25 was recorded on 01/02/25. SMA at 50 days reached $8.91, while 200 days put it at $5.96.
Levels Of Support And Resistance For AVXL Stock
The 24-hour chart illustrates a support level at 12.84, which if violated will result in even more drops to 12.23. On the upside, there is a resistance level at 14.16. A further resistance level may holdings at 14.87. The Relative Strength Index (RSI) on the 14-day chart is 70.82, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.93, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 15.86%. Stochastics %K at 76.37% indicates the stock is a holding.
How much short interest is there in Anavex Life Sciences Corporation?
A steep rise in short interest was recorded in Anavex Life Sciences Corporation stocks on 2024-11-29, growing by 1.38 million shares to a total of 19.69 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 18.31 million shares. There was a rise of 7.03%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on September 28, 2020 when Ladenburg Thalmann began covering the stock and recommended ‘”a Buy”‘ rating along with a $12 price target.
